Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

From MaRDI portal

Revision as of 21:50, 13 March 2024 by Import240313080341 (talk | contribs) (Created automatically from import240313080341)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Publication:5982928

Jump to:navigation, search

DOI10.1182/BLOODADVANCES.2020002517MaRDI QIDQ5982928

Anna Eriksson, Marie Engvall, Henrik Grönberg, Monika Jansson, Lucia Cavelier, Sofia Bengtzén, My Björklund, Philippe Ruminy, Johan Lindberg, Sören Lehmann, Christer Nilsson, Anne Neddermeyer, Andreas Lennartsson, Sylvain Mareschal, Mattias Rantalainen, Vinciane Marchand, Anna Palau, Fabrice Jardin

Publication date: 16 February 2021

Published in: Blood Advances (Search for Journal in Brave)

Related Items (1)

This page was built for publication: Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Publication:5982928&oldid=30859878"